The VHL tumor suppressor and HIF: insights from genetic studies in mice.

Kapitsinou PP, Haase VH
Cell Death Differ. 2008 15 (4): 650-9

PMID: 18219317 · PMCID: PMC3799983 · DOI:10.1038/sj.cdd.4402313

The von Hippel-Lindau tumor suppressor gene product, pVHL, functions as the substrate recognition component of an E3-ubiquitin ligase, which targets the oxygen-sensitive alpha-subunit of hypoxia-inducible factor (HIF) for rapid proteasomal degradation under normoxic conditions and as such plays a central role in molecular oxygen sensing. Mutations in pVHL can be found in familial and sporadic clear cell carcinomas of the kidney, hemangioblastomas of the retina and central nervous system, and pheochromocytomas, underscoring its gatekeeper function in the pathogenesis of these tumors. Tissue-specific gene targeting of VHL in mice has demonstrated that efficient execution of pVHL-mediated HIF proteolysis under normoxia is fundamentally important for survival, proliferation, differentiation and normal physiology of many cell types, and has provided novel insights into the biological function of individual HIF transcription factors. In this review, we discuss the role of HIF in the development of the VHL phenotype.

MeSH Terms (17)

Animals Basic Helix-Loop-Helix Transcription Factors Carcinoma, Renal Cell Gene Expression Regulation, Developmental Gene Expression Regulation, Neoplastic Genotype Germ-Line Mutation Humans Hypoxia-Inducible Factor 1, alpha Subunit Kidney Neoplasms Mice Mice, Knockout Neoplasms Phenotype Ubiquitin-Protein Ligases von Hippel-Lindau Disease Von Hippel-Lindau Tumor Suppressor Protein

Connections (2)

This publication is referenced by other Labnodes entities: